Francis Willard Sarena is VP & Secretary at FIVE PRIME THERAPEUTICS, INC. (FPRX). They have made 9 open-market trades across 1 company since 2016, most recently 2025-10-30.
CIK 0001175505
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FPRX | SELL | 2017-01-18 | 2017-01-18 | $47.39 | $172K | -5.9% | +2.5% | -29.8% |
| FPRX | SELL | 2017-01-18 | 2017-01-18 | $47.39 | $172K | -5.9% | +2.5% | -29.8% |
| FPRX | SELL | 2016-11-28 | 2016-11-30 | $60.14 | $206K | -11.3% | -13.2% | -20.5% |
| FPRX | SELL | 2016-11-25 | 2016-11-28 | $60.48 | $1.3M | -9.3% | -14.8% | -17.7% |
| FPRX | SELL | 2016-11-23 | 2016-11-28 | $60.38 | $2.1M | -9.3% | -14.8% | -17.7% |
| FPRX | SELL | 2016-11-23 | 2016-11-28 | $60.23 | $811K | -9.3% | -14.8% | -17.7% |
| FPRX | SELL | 2016-03-29 | 2016-03-31 | $40.01 | $622K | +10.6% | +19.7% | +2.8% |
| FPRX | SELL | 2016-01-27 | 2016-01-29 | $35.23 | $1.0M | -18.3% | -8.9% | +33.7% |
| FPRX | SELL | 2016-01-27 | 2016-01-29 | $35.22 | $1.1M | -18.3% | -8.9% | +33.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.